3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USE THEREOF IN TREATING DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 OF IKAROS (IKZF2) FAMILY Russian patent published in 2024 - IPC C07D401/04 C07D401/14 A61K31/454 A61K31/4545 A61P35/00 A61P35/02 

Abstract RU 2815714 C2

FIELD: chemistry.

SUBSTANCE: present invention relates to compounds based on 3-(5-amino-1-oxoisoindolin-2-yl) piperidine-2,6-dione, specifically to a compound of formula (I'), where each of X1 and X2 is independently H or halogen; Rx is H; each of Ra and Rb is independently H, or Ra and Rb together with the atom to which they are attached form =(O); R1 is or ; R2 is H or (C1-C6) alkyl; or R5 is -OR6 or -NR7R7'; R6 is H, (C1-C6) alkyl, wherein alkyl is optionally substituted with one substituent independently selected from phenyl; each of R7 and R7' independently represents H, (C1-C6) alkyl, wherein alkyl is optionally substituted with one to three R8; or R7 and R7' together with the nitrogen atom to which they are attached form 5-member heterocycloalkyl ring; each R8 is -C(O)OH, (C3-C7) cycloalkyl, phenyl or 6-member heteroaryl containing 1 heteroatom selected from N, wherein cycloalkyl is optionally substituted with one to four R10; each R10 independently in each occurrence is (C1-C6) alkyl; n1 equals 1, 2 or 3; each of n2 and n3 independently equals 1; or its pharmaceutically acceptable salts. Invention also relates to a compound selected from a group of individual compounds, a pharmaceutical composition, a method for breaking down IKZF2, a method of treating a disease or disorder, a method of modulating IKZF2 protein levels, a method of reducing IKZF2 protein levels, use of the compound of formula (I') in the manufacture of a drug preparation for treating a disease or disorder, use of the compound of formula (I') in treating the disease or disorder.

EFFECT: obtaining novel compounds which can be used in treating diseases or disorders associated with zinc finger protein 2 of the IKAROS (IKZF2) family.

25 cl, 21 tbl, 34 ex

(I')

Similar patents RU2815714C2

Title Year Author Number
3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 (IKZF2) OF THE IKAROS FAMILY 2019
  • Adcock, Claire
  • Bonazzi, Simone
  • Cernijenko, Artiom
  • Lam, Philip
  • Linkens, Kathryn Taylor
  • Malik, Hasnain Ahmed
  • Thomsen, Noel Marie-France
  • Visser, Michael Scott
RU2797559C2
COMPOSITIONS AND METHODS OF SELECTIVE PROTEIN DEGRADATION 2018
  • Golosov, Andrei
  • Goold, Carleton, Proctor
  • Guimaraes, Carle, Patricia Pinto
  • Hild, Marc Horst Peter
  • Motz, Gregory
  • Ross, Nathan Thomas
  • Solomon, Jonathan, M.
  • Beckwith, Rohan, Eric John
  • Carbonneau, Seth
  • Bradner, James, E.
RU2811700C2
TYPES OF COMBINATION THERAPY USING CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBITORS 2017
  • Anak, Ozlem
  • Bajlik, Sejnela
  • Brogdon, Dzhennifer
  • Kemeron, Dzhon, Skott
  • Chou, Uillyam
  • Khauard, Denni, Roland, Ml.
  • Isaaks, Randi
  • Dzhun, Karl, Kh.
  • Lejsi, Sajmon
  • Mod, Shennon
  • Milenkhorst, Yan, Dzh.
  • Shaster, Stiven
  • Kintas-Kardama, Alfonso
  • Grapp, Stefan
  • Bitter, Khans
RU2809160C2
TREATMENT OF MALIGNANT NEOPLASM USING HUMANIZED CHIMERIC ANTIGEN RECEPTOR AGAINST BCMA 2015
  • Brogdon, Jennifer
  • Choi, Eugene
  • Ebersbach, Hilmar
  • Glass, David
  • Huet, Heather
  • June, Carl, H.
  • Mannick, Joan
  • Milone, Michael, C.
  • Murphy, Leon
  • Plesa, Gabriela
  • Richardson, Celeste
  • Ruella, Marco
  • Singh, Reshma
  • Wang, Yongqiang
  • Wu, Qilong
RU2751660C2
CHIMERIC HUMAN MESOTHELIOGEN ANTIGEN RECEPTORS AND USE THEREOF 2014
  • Bitti Gregori
  • Engels Boris
  • Idamakanti Neeradzha
  • Dzhun Karl Kh.
  • Lev Andreas
  • Sun Khuejtszyuan
  • U Tsilun
RU2714902C2
CD20 THERAPY, CD22 THERAPY AND COMBINATION THERAPY WITH CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR (CAR) K CD19 2016
  • Bitter, Hans
  • Bordeaux,Jennifer, Mary
  • Brannetti, Barbara
  • Brogdon, Jennifer
  • Dakappagari, Naveen, Kumar
  • Gill, Saar
  • Highfill, Steven
  • Huang, Lu
  • June, Carl, H.
  • Kim, Ju, Young
  • Lei, Ming
  • Li, Na
  • Loew, Andreas
  • Orlando, Elena
  • Ruella, Marco
  • Tran, Thai
  • Zhahg, Jimin
  • Zhou, Li
RU2752918C2
METHODS FOR PRODUCING CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR 2015
  • Bedoya Felipe
  • Ghassemi Saba
  • June Carl H.
  • Levine Bruce L.
  • Melenhorst Jan J.
  • Milone Michael C.
  • Powell Daniel J. Jr.
  • Zheng Zoe
RU2751362C2
CHIMERIC ANTIGENIC (CAR) RECEPTOR AGAINST CD123 FOR USE IN TREATING MALIGNANT TUMORS 2015
  • Brogdon, Jennifer
  • Gill, Saar
  • Glass, David
  • Kenderian, Saad
  • Loew, Andreas
  • Mannick, Joan
  • Milone, Michael
  • Murphy, Leon
  • Porter, David, L.
  • Ruella, Marco
  • Wang, Yongqiang
  • Wu, Qilong
  • Zhang, Jiquan
RU2724999C2
COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN EXPRESSION 2017
  • Golosov, Andrei
  • Guimaraes, Carla
  • Motz, Gregory
  • Milone, Michael
  • Ellebrecht, Christoph, T.
  • Payne, Aimee, S.
RU2795467C2
BISPECIFIC 2+1 ANTIBODIES 2018
  • Amann Maria
  • Ferrara Koller Claudia
  • Flury Reto
  • Georges Guy
  • Grau-Richards Sandra
  • Haas Alexander
  • Hesse Friederike
  • Imhof-Jung Sabine
  • Klein Christian
RU2797305C2

RU 2 815 714 C2

Authors

Beckwith, Rohan Eric John

Bonazzi, Simone

Cernijenko, Artiom

Ma, Fupeng

Ware, Nathaniel F.

Dates

2024-03-20Published

2019-07-08Filed